thrombocytopenia/затлъстяване

Линкът е запазен в клипборда

Изберете тип сортиране

Страница 1 от 169 резултата

Immune Thrombocytopenia and Obesity: Predictive Relationship.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND Chronic refractory immune thrombocytopenia (ITP) is defined as the failure of any modality to maintain the platelet count above 20 × 103/μL for an appreciable time without unacceptable toxicity. To date, certain predictive factors have been associated with refractory ITP. However, none of

Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

A 32-year-old, morbidly obese African-American woman developed bilateral pulmonary emboli 12 days after undergoing Roux-en-Y gastric bypass surgery. Three days later, after receiving heparin and warfarin, she developed heparin-induced thrombocytopenia type II (HIT-II). An argatroban

Comparison of bivalirudin dosing strategies using total, adjusted, and ideal body weights in obese patients with heparin-induced thrombocytopenia.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

OBJECTIVE To compare dosing strategies using total body weight (actual measured body weight), adjusted body weight, and ideal body weight when starting bivalirudin for the treatment for heparin-induced thrombocytopenia (HIT) in obese patients, and to compare differences in dosing requirements and

Fondaparinux in an obese child with heparin-induced thrombocytopenia and a history of renal failure.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

A 9-year-old obese child with a history of ulcerative colitis was admitted to the intensive care unit for significant blood loss, hemorrhagic shock, and acute renal failure. Following complications from total colectomy secondary to multiple perforations, the patient developed heparin-induced

Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Heparin is widely used to prevent clotting of the extracorporeal circuit during haemodialysis (HD). Heparin-induced thrombocytopenia (HIT) is a potentially devastating immune mediated adverse drug reaction caused by the emergence of antibodies that activate platelets in the presence of

The effect of obesity on the rate of heparin-induced thrombocytopenia.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

: Heparin-induced thrombocytopenia (HIT) occurs in patients receiving heparin-containing products due to the formation of platelet-activating antibodies to heparin and platelet factor 4. Diagnosis includes utilization of a scoring system known as the 4-T score, and HIT laboratory assays. Recently,

Recommendations for the use of the non-obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug-induced thrombocytopenia: communication from the SSC of the ISTH.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

[The diagnosis of minor hypothyroid states: the HAPO syndrome (hypothyroidism-anemia-thrombopenia-obesity syndrome)].

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Impact of obesity on heparin-induced thrombocytopenia in cardiac surgery patients.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Overweight individuals are at increased risk for thrombotic thrombocytopenic purpura.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Our understanding of the pathophysiology of thrombotic thrombocytopenic purpura, TTP, has increased dramatically in the past few years with the identification of the role of ADAMTS13. Nonetheless, risk factors for the development of acute TTP are few. Informally, obesity was felt to be common in

Mefloquine adverse effects with atypical facial lesions in an overweight patient.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND The recommended dosage of mefloquine to treat Plasmodium falciparum infection is 25 mg/kg, with no recommendation for dosage exceeding 1500 mg. We describe an original case of adverse reaction to mefloquine in an overweight patient. METHODS Case report. RESULTS A 32-year-old woman

Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

BACKGROUND Immune thrombocytopenia (ITP) is increasingly recognized as a thrombophilic disorder. However, no further investigation of risk factors has been conducted to date. This study evaluated classic and disease-specific correlates of thrombosis among ITP patients. We hypothesized the

Vaginosonographically guided paracentesis in a woman with severe thrombocytopenia.

Само регистрирани потребители могат да превеждат статии

Вход / Регистрация

Coagulation disorders and obesity might complicate transabdominal paracentesis. In a woman with severe thrombocytopenia we used the vaginal approach guided by vaginosonography to obtain ascitic fluid for analysis.

Предишна
1
2
3
4
5
6
...
11
12
Следваща

Присъединете се към нашата
страница във facebook

Herbal & Natural Medicine

Най-пълната база данни за лечебни билки, подкрепена от науката

Работи на 55 езика
Билкови лекове, подкрепени от науката
Разпознаване на билки по изображение
Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
Прочетете научни публикации, свързани с вашето търсене
Търсете лечебни билки по техните ефекти
Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания